{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:05:26Z","timestamp":1779768326937,"version":"3.53.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,25]]},"DOI":"10.7759\/cureus.109645","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T03:47:05Z","timestamp":1779767225000},"source":"Crossref","is-referenced-by-count":0,"title":["Advanced Cirrhosis Is Independently Associated With Increased In-Hospital Mortality in Heart Failure With Reduced Ejection Fraction"],"prefix":"10.7759","author":[{"given":"Teddy A","family":"Teddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edidiong","family":"Okon-Ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraol T","family":"Erega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Cadet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Marzoung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Vummaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelwahab","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani SS","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, et al.. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021, 143:e254-743. 10.1161\/CIR.0000000000000950","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham WT","year":"2005","unstructured":"Abraham WT, Adams KF, Fonarow GC, et al.. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005, 46:57-64. 10.1016\/j.jacc.2005.03.051","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14175993","article-title":"Cirrhotic cardiomyopathy: bridging hepatic and cardiac pathophysiology in the modern era","volume":"14","author":"Lupu D","year":"2025","unstructured":"Lupu D, Sc\u00e2rneciu CC, \u021a\u00een\u021b D, Tudoran C. Cirrhotic cardiomyopathy: bridging hepatic and cardiac pathophysiology in the modern era. J Clin Med. 2025, 14:10.3390\/jcm14175993","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010057","article-title":"B-blockers in liver cirrhosis: a wonder drug for every stage of portal hypertension? A narrative review","volume":"12","author":"Karagiannakis DS","year":"2023","unstructured":"Karagiannakis DS, Karakousis ND, Androutsakos T. B-blockers in liver cirrhosis: a wonder drug for every stage of portal hypertension? A narrative review. Biomedicines. 2023, 12:10.3390\/biomedicines12010057","journal-title":"Biomedicines"},{"key":"ref5","unstructured":"AHRQ HCUP NIS overview. Overview of the National (Nationwide) Inpatient Sample (NIS). (2022). http:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16806","article-title":"Systematic review: development of a consensus code set to identify cirrhosis in electronic health records","volume":"55","author":"Shearer JE","year":"2022","unstructured":"Shearer JE, Gonzalez JJ, Min T, et al.. Systematic review: development of a consensus code set to identify cirrhosis in electronic health records. Aliment Pharmacol Ther. 2022, 55:645-57. 10.1111\/apt.16806","journal-title":"Aliment Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11925","article-title":"A data-envelopment analysis-based systematic review of the literature on innovation performance","volume":"8","author":"Narayanan E","year":"2022","unstructured":"Narayanan E, Binti Ismail WR, Bin Mustafa Z. A data-envelopment analysis-based systematic review of the literature on innovation performance. Heliyon. 2022, 8:e11925. 10.1016\/j.heliyon.2022.e11925","journal-title":"Heliyon"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser A","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998, 36:8-27. 10.1097\/00005650-199801000-00004","journal-title":"Med Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12451018","article-title":"Hepatorenal syndrome","volume":"14","author":"Francoz C","year":"2019","unstructured":"Francoz C, Durand F, Kahn JA, Genyk YS, Nadim MK. Hepatorenal syndrome. Clin J Am Soc Nephrol. 2019, 14:774-81. 10.2215\/CJN.12451018","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/heart.87.1.9","article-title":"Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease","volume":"87","author":"M\u00f8ller S","year":"2002","unstructured":"M\u00f8ller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart. 2002, 87:9-15. 10.1136\/heart.87.1.9","journal-title":"Heart"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.210","article-title":"Cirrhotic cardiomyopathy: pathogenesis and clinical relevance","volume":"11","author":"Wiese S","year":"2014","unstructured":"Wiese S, Hove JD, Bendtsen F, M\u00f8ller S. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2014, 11:177-86. 10.1038\/nrgastro.2013.210","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/17562848261423358","article-title":"Cirrhotic cardiomyopathy: pathophysiology, assessment, and implications for liver transplantation","volume":"19","author":"Gill M","year":"2026","unstructured":"Gill M, Koshy AN, Ramachandran J, McCaughan GW, Majumdar A. Cirrhotic cardiomyopathy: pathophysiology, assessment, and implications for liver transplantation. Ther Adv Gastroenterol. 2026, 19:17562848261423358. 10.1177\/17562848261423358","journal-title":"Ther Adv Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","unstructured":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018, 69.406-60. 10.1016\/j.jhep.2018.03.024","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.08.1654","article-title":"Cardiac hepatopathy versus end-stage liver disease: two different entities","volume":"63","author":"Valentova M","year":"2014","unstructured":"Valentova M, von Haehling S, Anker SD, Sandek A. Cardiac hepatopathy versus end-stage liver disease: two different entities. J Am Coll Cardiol. 2014, 63:1809-10. 10.1016\/j.jacc.2013.08.1654","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"136","author":"Yancy CW","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017, 136:e137-61. 10.1161\/CIR.0000000000000509","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2022.11.032","article-title":"Risks of heart failure, stroke, and bleeding in atrial fibrillation according to heart failure phenotypes","volume":"9","author":"Inciardi RM","year":"2023","unstructured":"Inciardi RM, Giugliano RP, Park JG, et al.. Risks of heart failure, stroke, and bleeding in atrial fibrillation according to heart failure phenotypes. JACC Clin Electrophysiol. 2023, 9:569-80. 10.1016\/j.jacep.2022.11.032","journal-title":"JACC Clin Electrophysiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-020-00183-6","article-title":"In-hospital outcomes of patients with acute decompensated heart failure and cirrhosis: an analysis of the National Inpatient Sample","volume":"9","author":"Khalid YS","year":"2020","unstructured":"Khalid YS, Reja D, Dasu NR, Suga HP, Dasu KN, Joo LM. In-hospital outcomes of patients with acute decompensated heart failure and cirrhosis: an analysis of the National Inpatient Sample. Cardiol Ther. 2020, 9:433-45. 10.1007\/s40119-020-00183-6","journal-title":"Cardiol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.10.007","article-title":"Heart failure and liver disease: cardiohepatic interactions","volume":"7","author":"Xanthopoulos A","year":"2019","unstructured":"Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart failure and liver disease: cardiohepatic interactions. JACC Heart Fail. 2019, 7:87-97. 10.1016\/j.jchf.2018.10.007","journal-title":"JACC Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2025.270","article-title":"Cirrhotic cardiomyopathy: a systematic review and meta-analysis of prevalence across various diagnostic approaches","volume":"45","author":"Ewid M","year":"2025","unstructured":"Ewid M, Alsagaby S, Al-Ruqi A, Al-Shamikh O, Aljohani A, Bourgleh MS, Safwana M. Cirrhotic cardiomyopathy: a systematic review and meta-analysis of prevalence across various diagnostic approaches. Ann Saudi Med. 2025, 45:270-93. 10.5144\/0256-4947.2025.270","journal-title":"Ann Saudi Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.89871","article-title":"Decoding silent signals: a systematic review of ECG and the quest for an early diagnosis of cirrhotic cardiomyopathy","volume":"17","author":"Neelakantan Ramaswamy S","year":"2025","unstructured":"Neelakantan Ramaswamy S, Harikrishnan S, Bhatt N, Agarwal Y, Chand S, Bendagiri Matam M, Mohammed L. Decoding silent signals: a systematic review of ECG and the quest for an early diagnosis of cirrhotic cardiomyopathy. Cureus. 2025, 17:e89871. 10.7759\/cureus.89871","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/medsci13010019","article-title":"Outcomes in acute decompensated congestive heart failure admissions with chronic liver disease: a nationwide analysis using the National Inpatient Sample","volume":"13","author":"Varughese VJ","year":"2025","unstructured":"Varughese VJ, Nagesh VK, Moliya P, et al.. Outcomes in acute decompensated congestive heart failure admissions with chronic liver disease: a nationwide analysis using the National Inpatient Sample. Med Sci (Basel). 2025, 13:10.3390\/medsci13010019","journal-title":"Med Sci (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485444-advanced-cirrhosis-is-independently-associated-with-increased-in-hospital-mortality-in-heart-failure-with-reduced-ejection-fraction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T03:47:09Z","timestamp":1779767229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485444-advanced-cirrhosis-is-independently-associated-with-increased-in-hospital-mortality-in-heart-failure-with-reduced-ejection-fraction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.109645","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,25]]}}}